• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Home
  • LinkedIn
  • Twitter

  • About Us
    • Overview
    • Executive Committee
    • Board Of Directors
    • Partners
  • Science
    • Overview
    • Approach
    • Technology
      • shRNA
      • shARC Platform
    • Scientific Publications
  • Pipeline
  • Newsroom
    • Press Releases
    • Events
    • Media Center
  • Investors
    • Overview
    • Analyst Coverage
    • Corporate Governance
    • Regulated Information
    • Shareholders Information
    • Shareholders Meeting
  • Careers
  • Contact Us
  • Home
  • About Us

About Us

About Us

Overview

 

Celyad Oncology is a biotechnology company focused on the discovery and development of innovative technologies for chimeric antigen receptor (CAR) T-cell therapies. The Company is focusing on opportunities to fully harness the true potential of its proprietary technology platforms and intellectual property and support the development of next-generation CAR T-cell candidates in solid tumors and hematological malignancies.

Celyad Oncology’s headquarters are located in Mont-Saint-Guibert, Belgium.

about_us

Celyad Oncology is committed to delivering innovative immunotherapies to patients with advanced cancer seeking novel treatment options

Mission & Vision

Developing innovative cell therapies against cancer

At Celyad Oncology, we are driven by the promise of delivering relevant treatment options to patients. Our goal is to discover, develop and contribute meaningfully to new therapies that will irradicate cancer. We believe that our innovative CAR T-cell candidates could offer patients with advanced disease alternative therapeutic options where no other treatments exist. Delivering best-in-class cell therapies for patients with unmet medical needs is our top priority.

At Celyad Oncology, our goal is to eliminate cancer and improve life.

Management Team

Footer

Celyad Oncology

Celyad Oncology Logo
  • About
  • Science
  • Pipeline
  • Newsroom
  • Investors
  • Contact Us
  • LinkedIn
  • Twitter

Copyright © 2020 All Rights Reserved.

  • Cookie Policy |
  • Privacy Policy |
  • Terms of Use